This article provides a comprehensive exploration of artificial intelligence (AI) in predicting pharmacokinetic (PK) parameters.
This article explores the transformative integration of artificial intelligence (AI) with Physiologically Based Pharmacokinetic (PBPK) modeling for predicting drug behavior in the human body.
This article provides a comprehensive analysis for researchers, scientists, and drug development professionals on the transformative impact of artificial intelligence (AI) in drug discovery.
This comprehensive article explores the transformative role of Artificial Intelligence and Machine Learning in small molecule lead optimization for drug discovery.
This article provides a detailed overview of computational ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) prediction for researchers and drug development professionals.
Natural compounds offer immense therapeutic potential but face significant hurdles in Absorption, Distribution, Metabolism, and Excretion (ADME) properties, often leading to high attrition rates in drug development.
This article provides a comprehensive analysis of Absorption, Distribution, Metabolism, and Excretion (ADME) processes in pediatric and geriatric populations, highlighting their critical differences from the standard adult model.
This article provides a comprehensive guide for researchers and drug development professionals on the application of 3D cultured hepatocytes in Cytochrome P450 (CYP) inhibition studies.
This article provides a detailed comparative analysis of 2D and 3D cell culture models for modern drug screening.
This article provides a comprehensive guide for researchers and drug development professionals on addressing the critical challenge of chemical instability in drug formulations.